English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

New challenges and the state of development of COVID-19 in connection with the spread of new strains of SARS-CoV-2 have been analyzed. Experience and knowledge in working with new means of protection of different types of vaccines are studied: both classic, based on inactivated virus or its fragment, and the new generation – with vector and genetic mRNA vaccines, as well as effective antiviral drugs. Biorisks and compliance with biosafety principles have been studied. The replenishment of the base of competencies for biotechnologists and pharmacists in the context of distance learning and response to the pandemic is considered. The new data were used to introduce and deepen knowledge about the new generation of vaccines and the dangers of dual use of experimental data in the development of new components of educational programs in "Biotechnology and Bioengineering" and “Pharmacy, Industrial Pharmacy”.

Formation of experience against the challenges of viral infection through the use of students knowledge of biosafy technologies, part 1